Subgroup analysis based on MSA typing showed remarkably higher incidence of fever, arthritis, and ILD in the anti-MDA5 and anti-ARS groups than that in the other antibody-positive group (group III). This evidence concerns the gene IFIH1 and interstitial lung disease.